You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Toripalimab

Showing 1 - 25 of 351
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Carcinoma Trial in Shijiazhuang (toripalimab)

Recruiting
  • Esophageal Carcinoma
  • toripalimab
  • Shijiazhuang, Hebei, China
    Fourth Hospital of Hebei Medical University
Aug 20, 2023

Ampullary Carcinoma Trial (Surufatinib+Toripalimab+AG)

Not yet recruiting
  • Ampullary Carcinoma
  • (no location specified)
Sep 29, 2023

Advanced Urothelial Carcinoma Trial in Beijing (9MW2821, Toripalimab)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Oct 9, 2023

Advanced Solid Tumor Trial in Shanghai (RC118, Toripalimab)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, China
    hongshan Hospital Affiliated to Fudan University
Sep 14, 2023

Nasopharyngeal Carcinoma Trial in Hangzhou (Toripalimab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Toripalimab
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Apr 2, 2023

Solid Tumor Trial in Changchun (WX390, Toripalimab)

Recruiting
  • Solid Tumor
  • Changchun, Jilin, China
    the first affiliated hospital of Jilin university
Nov 3, 2023

Gastric Cancer, Pancreatic Cancer Trial (LM302+Toripalimab)

Not yet recruiting
  • Gastric Cancer
  • Pancreatic Cancer
  • (no location specified)
Jun 28, 2023

Cervical Cancer, Induction Chemo, Immunotherapy Trial in Tianjin (Toripalimab)

Recruiting
  • Cervical Cancer
  • +2 more
  • Toripalimab
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Oct 16, 2023

Limited-stage Small Cell Lung Cancer (LS-SCLC) Trial in Jinan (Tifcemalimab injection, toripalimab injection, Placebo for

Not yet recruiting
  • Limited-stage Small Cell Lung Cancer (LS-SCLC)
  • Tifcemalimab injection
  • +3 more
  • Jinan, Shandong, China
    Shandong Cancer Hospital & Institute
Oct 18, 2023

Locally Advanced Hypopharyngeal Carcinoma Trial in Shanghai (drug, procedure, radiation)

Not yet recruiting
  • Locally Advanced Hypopharyngeal Carcinoma
  • three cycles (toripalimab + cetuximab + platinum)
  • +2 more
  • Shanghai, Shanghai, China
    Eye & ENT Hospital of Fudan University
Nov 22, 2023

Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (PD-1 inhibitor)

Recruiting
  • Gastric or Gastroesophageal Junction Adenocarcinoma
  • PD-1 inhibitor
  • Guangzhou, China
    Sun Yat-sen University Cancer Center
Aug 9, 2023

NSCLC Trial in Shanghai (Toripalimab, Cryoablation)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Toripalimab
  • Cryoablation
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Nov 7, 2023

Gastroesophageal Adenocarcinoma Trial (toripalimab FOLFOX)

Not yet recruiting
  • Gastroesophageal Adenocarcinoma
  • toripalimab FOLFOX
  • (no location specified)
Aug 3, 2023

Gastric Type Adenocarcinoma (GAS) With STK11 Mutation Trial in Shanghai (WX390, Toripalimab)

Recruiting
  • Gastric Type Adenocarcinoma (GAS) With STK11 Mutation
  • Shanghai, Shanghai, China
    The Obstetrics & Gynecology Hospital of Fudan University (Shangh
Nov 3, 2023

Microsatellite Stable Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Toripalimab, High/low-dose radiotherapy)

Recruiting
  • Microsatellite Stable Metastatic Colorectal Cancer
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 19, 2023

Esophageal Carcinoma, Neoadjuvant Therapy Trial (Toripalimab, Anlotinib HCl, Albumin paclitaxel)

Not yet recruiting
  • Esophageal Carcinoma
  • Neoadjuvant Therapy
  • Toripalimab
  • +3 more
  • (no location specified)
Aug 16, 2023

Melanoma Stage III Trial in Shanghai (Toripalimab combined with Temozolomide)

Not yet recruiting
  • Melanoma Stage III
  • Toripalimab combined with Temozolomide
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 23, 2023

Non Squamous Non Small Cell Lung Cancer, EGFR Positive NSCLC Trial (Toripalimab plus Chemotherapy)

Not yet recruiting
  • Non Squamous Non Small Cell Lung Cancer
  • EGFR Positive Non-small Cell Lung Cancer
  • Toripalimab plus Chemotherapy
  • (no location specified)
Jul 28, 2023

Head Neck Cancer, Cervical Cancer, Endometrial Cancer Trial (ILB-2109, Toripalimab)

Not yet recruiting
  • Head and Neck Cancer
  • +9 more
  • (no location specified)
Jul 12, 2023

Gastric Cancer Trial in Beijing (RC48-ADC, Herceptin, Toripalimab)

Not yet recruiting
  • Gastric Cancer
  • Beijing, China
    Beijing Cancer Hospital
Aug 7, 2023

NSCLC Trial in Shanghai (SBRT+LDRT, Toripalimab, Chemotherapy drug)

Recruiting
  • NSCLC
  • SBRT+LDRT
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Apr 2, 2023

Toripalimab, First-line Treatment Trial in Guangzhou (EP/EC+PD-1)

Recruiting
  • Toripalimab
  • First-line Treatment
  • Guangzhou, Guangdong, China
    Sun Yat-sen University cancer center
Mar 7, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Hangzhou (Toripalimab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Toripalimab
  • Hangzhou, Zhejiang, China
    Department of Medical Onocology, First Affiliated Hospital of Zh
Oct 7, 2023

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Capecitabine, oxaliplatin, Disitamab Vedotin)

Not yet recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Beijing, Beijing, China
  • +10 more
Nov 23, 2023

Local Advanced NSCLC Trial (Toripalimab, Radical thoracic radiotherapy)

Not yet recruiting
  • Local Advanced Non-small Cell Lung Cancer
  • Toripalimab
  • Radical thoracic radiotherapy
  • (no location specified)
Jun 2, 2023